← Back to Patent Explorer
US5360739A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for the identification and characterization of reticulocytes in whole blood

Assignee: Icahn School of Medicine at Mount Sinai
•
Filing: 1991-12-05
•
Granted: 1994-11-01
•
Expires: 2011-12-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods for characterizing and distinguishing reticulocytes and mature red blood cells use reagent compositions which include an organic cationic dye for staining the reticulocytes in the blood sample and a buffer solution for maintaining a pH of about 6 to about 9. The dyes may be the red excitable fluorescent dye Oxazine 750, or the blue excitable fluorescent dyes Acridine Orange or derivatives of Acridine Orange. When a zwitterionic surfactant is included in the reagent composition for isovolumetric sphering of the reticulocytes and erythrocytes, and the reagent composition and whole blood sample mixture is passed through the sensing region of a flow cytometer, the light scattered through at least one angular interval and that fluoresced by each cell is measured, the erythrocytes can be distinguished from reticulocytes and the volume, hemoglobin concentration and the hemoglobin content of each reticulocyte or erythrocyte, and the mean cell volume, mean corpuscular hemoglobin concentration, and mean cell hemoglobin of the reticulocytes and/or erythrocytes are calculated from the measured cell-by-cell volume and hemoglobin concentration.

Inventors

  • 👤 Sophie S. Fan
  • 👤 Daniel Ben-David
  • 👤 Gregory M. Colella
  • 👤 Albert Cupo
  • 👤 Gena Fischer
  • 👤 Leonard Ornstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 21:09
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/80; G01N1/00; G01N1/28; G01N1/30; G01N15/00; G01N15/10; G01N15/14; G01N15/1456; G01N15/1459; G01N33/5005; G01N33/5094; G01N1/38; G01N15/1429; G01N15/1433; G01N15/01; G01N2015/012; G01N2015/014; G01N2015/1486; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10T; Y10T436/00; Y10T436/10; Y10T436/101666

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 140 words
A method for identifying subclasses of cells of interest in a blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with an aqueous reagent composition to form a suspension, wherein the reagent composition comprises a dye compound which stains the ribonucleic acid of cells in the subclass of interest, a buffer for maintaining a pH of about 6 to about 9, and a sphering agent which is a zwitterionic surfactant and which does not precipitate said dye; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting the light scattered and light fluoresced by each cell; and (d) differentiating said cells of said subclass of interest at least in part on the basis of said scattered and fluoresced light.
Claim 2
Independent Claim 140 words
A method for identifying subclasses of cells of interest in a blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with an aqueous reagent composition to form a suspension, wherein the reagent composition comprises a dye compound which stains the ribonucleic acid of cells in the subclass of interest, a buffer for maintaining a pH of about 6 to about 9, and a sphering agent which is a zwitterionic surfactant and which does not precipitate said dye; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting the light scattered and light fluoresced by each cell; and (d) differentiating said cells of said subclass of interest at least in part on the basis of said scattered and fluoresced light.
Claim 3
Dependent Claim 12 words
The method of claim 1 wherein the subclass of cells is reticulocytes.
Claim 4
Dependent Claim 23 words
The method of claim 1 wherein said optical illumination in step (b) has an excitation wavelength in the red region of the spectrum.
Claim 5
Dependent Claim 23 words
The method of claim 1 wherein said optical illumination in step (b) has an excitation wavelength in the blue region of the spectrum.
Claim 6
Dependent Claim 16 words
The method of claim 1, wherein the dye compound is Oxazine 750 having the formula: ##STR3##
Claim 7
Dependent Claim 12 words
The method of claim 1 wherein the dye compound is Oxazine 750.
Claim 8
Dependent Claim 27 words
The method of claim 1, wherein the reagent composition comprises the dye Oxazine 750 at a concentration range of from about 0.2 μg/mL to about 1.2 μg/mL.
Claim 9
Dependent Claim 27 words
The method of claim 7, wherein the reagent composition comprises the dye Oxazine 750 at a concentration range of from about 0.4 μg/mL to about 0.6 μg/mL.
Claim 10
Dependent Claim 15 words
The method of claim 1, wherein the surfactant is an alkylamidobetaine or an alkyl betaine.
Claim 11
Dependent Claim 10 words
The method of claim 9, wherein the surfactant is lauramidopropylbetaine.
Claim 12
Dependent Claim 22 words
The method of claim 1, wherein the surfactant is present in an amount of from about 12 μg/mL to about 87.5 μg/mL.
Claim 13
Dependent Claim 90 words
The method of claim 1, wherein said buffer comprises one or more of: K/NaHCO 3 at a concentration of from about 5 mM to about 50 mM; Mg Cl 2 at a concentration of from about 0 mM to about 88 mM; KCl at a concentration of from about 4 mM to about 104 mM; Na 3 PO at a concentration of from about 0 mM to about 0.4 mM; such that the final osmolality of the reagent composition being from about 270 m Osm to about 310 m Osm.
Claim 14
Dependent Claim 75 words
The method of claim 1, wherein said buffer comprises one or more of: Tris at a concentration of from about 0 mM to about 150 mM; K 2 Ox/EDTA at a concentration of from about 0 mM to about 121 mM; and Barbital at a concentration of from about 0 mM to about 155 mM; such that the final osmolality of the reagent composition being from about 280 m Osm to about 300 m Osm.
Claim 15
Independent Claim 146 words
A method for characterizing reticulocytes and erythrocytes in a whole blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with a reagent composition comprising an organic cationic dye compound, a sphering agent which is a zwitterionic surfactant and which does not precipitate said dye, and a buffer solution to form a suspension, wherein said dye compound stains the ribonucleic acid of the reticulocytes; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting the light scattered and light fluoresced by each cell; (d) identifying stained cells and unstained cells on the basis of the light scattered and light fluoresced; and (e) determining the number, the volume, hemoglobin concentration, and RNA concentration of the reticulocytes or erythrocytes on the basis of said scattered and fluoresced light.
Claim 16
Independent Claim 146 words
A method for characterizing reticulocytes and erythrocytes in a whole blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with a reagent composition comprising an organic cationic dye compound, a sphering agent which is a zwitterionic surfactant and which does not precipitate said dye, and a buffer solution to form a suspension, wherein said dye compound stains the ribonucleic acid of the reticulocytes; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting the light scattered and light fluoresced by each cell; (d) identifying stained cells and unstained cells on the basis of the light scattered and light fluoresced; and (e) determining the number, the volume, hemoglobin concentration, and RNA concentration of the reticulocytes or erythrocytes on the basis of said scattered and fluoresced light.
Claim 17
Dependent Claim 27 words
The method of claim 14 wherein the reagent composition comprises the dye Oxazine 750 at a concentration range of from about 0.2 μg/mL to about 1.2 μg/mL.
Claim 18
Dependent Claim 19 words
The method of claim 14 wherein the pH of the reagent composition is between about 6 and about 9.
Claim 19
Dependent Claim 92 words
The method of claim 14 wherein the buffer solution comprises one or more: of K/NaHCO 3 at a concentration of from about 5 mM to about 50 mM; Mg Cl 2 at a concentration of from about 0 mM to about 88 mM; KCl at a concentration of from about 4 mM to about 104 mM; Na 3 PO 4 at a concentration of from about 0 mM to about 0.4 mM; such that the final osmolality of the reagent composition being from about 270 m Osm to about 310 m Osm.
Claim 20
Dependent Claim 76 words
The method of claim 14 wherein the buffer solution comprises one or more: of Tris at a concentration of from about 0 mM to about 150 mM; K 2 Ox/EDTA at a concentration of from about 0 mM to about 121 mM; and Barbital at a concentration of from about 0 mM to about 155 mM; such that the final osmolality of the reagent composition being from about 280 m Osm to about 300 m OSm.
Claim 21
Dependent Claim 15 words
The method of claim 14 wherein said surfactant is an alkylamidobetaine or an alkyl betaine.
Claim 22
Dependent Claim 10 words
The method of claim 19, wherein said surfactant is lauramidopropylbetaine.
Claim 23
Dependent Claim 22 words
The method of claim 14 wherein said surfactant is present in an amount of from about 12 μg/mL to about 87.5 μg/mL.
Claim 24
Dependent Claim 27 words
The method of claim 15, wherein the reagent composition comprises the dye Oxazine 750 at a concentration range of from about 0.4 μg/mL to about 0.6 μg/mL.
Claim 25
Dependent Claim 23 words
The method of claim 14, wherein said optical illumination in step (b) has an excitation wavelength in the red region of the spectrum.
Claim 26
Dependent Claim 23 words
The method of claim 14, wherein said optical illumination in step (b) has an excitation wavelength in the blue region of the spectrum.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-10-31 1998-05-02 1998-11-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-10-31 2002-05-02 2002-11-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-10-31 2006-05-02 2006-11-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag